Celldex Therapeutics, Inc.
CLDX
$41.95
-$0.66-1.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.84% | -32.95% | -28.50% | -22.85% | -21.44% |
| Total Receivables | 155.56% | -78.38% | 187.86% | -89.44% | -94.13% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -60.43% | -61.17% | -33.53% | -4.39% | 121.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.80% | -33.81% | -28.44% | -22.41% | -20.14% |
|
|
|||||
| Total Current Assets | 11.80% | -33.81% | -28.44% | -22.41% | -20.14% |
| Net Property, Plant & Equipment | 96.91% | 15.93% | -5.74% | 1.97% | 18.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 65.96% | 48.28% | 37.05% | -3.93% | 8,591.59% |
| Total Assets | 12.99% | -30.86% | -26.42% | -21.23% | -18.12% |
|
|
|||||
| Total Accounts Payable | 607.91% | 203.78% | -63.86% | 283.03% | -45.48% |
| Total Accrued Expenses | 54.32% | 50.92% | 38.97% | 40.81% | 52.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.37% | -2.27% | 6.89% | 12.62% | -3.34% |
| Total Finance Division Other Current Liabilities | 32.26% | -25.59% | 30.57% | -33.38% | -74.68% |
| Total Other Current Liabilities | 32.26% | -25.59% | 30.57% | -33.38% | -74.68% |
| Total Current Liabilities | 86.04% | 60.76% | 29.09% | 44.78% | 19.18% |
|
|
|||||
| Total Current Liabilities | 86.04% | 60.76% | 29.09% | 44.78% | 19.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 123.88% | -77.03% | -66.79% | -37.47% | 87.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22.41% | 22.41% | 16.41% | -26.78% | -26.78% |
| Total Liabilities | 83.20% | 50.80% | 23.12% | 34.35% | 15.89% |
|
|
|||||
| Common Stock & APIC | 15.61% | 1.64% | 1.68% | 1.68% | 1.75% |
| Retained Earnings | -18.04% | -17.63% | -16.64% | -14.89% | -13.62% |
| Treasury Stock & Other | -61.13% | -29.32% | 9.41% | -28.80% | 87.58% |
| Total Common Equity | 9.03% | -35.10% | -29.43% | -23.86% | -19.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.03% | -35.10% | -29.43% | -23.86% | -19.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.03% | -35.10% | -29.43% | -23.86% | -19.45% |
|
|
|||||